首页> 美国卫生研究院文献>Iranian Journal of Pharmaceutical Research : IJPR >Antidiabetic Activities of Aqueous Stem Bark Extract of Strychnoshenningsii Gilg in Streptozotocin-nicotinamide Type 2 Diabetic Rats
【2h】

Antidiabetic Activities of Aqueous Stem Bark Extract of Strychnoshenningsii Gilg in Streptozotocin-nicotinamide Type 2 Diabetic Rats

机译:马兜铃提取物对链脲佐菌素-烟酰胺2型糖尿病大鼠的抗糖尿病作用。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Strychnos henningsii Gilg is recommended among other remedies for the treatment of diabetes in traditional medicine of Southern Africa. The antidiabetic effect of oral administration of aqueous bark extract of the plant at 125, 250 and 500 mg/Kg body weight was investigated in diabetic rats induced with streptozotocin-nicotinamide for 15 days. The extract decreased the blood glucose level, feed and water intake as well as triacylglycerol at the three doses investigated while the best result was obtained at 250 mg/Kg. Similarly, the extract was able to lower the cholesterol level appreciably at 500 mg/Kg while the remaining doses did not have any significant effect as compared with diabetic untreated groups. In addition, the weight loss of diabetic-treated rats was markedly normalized at all doses. The glucose tolerance level of diabetic animals was effectively reduced to near normal level after 90 min of extract administration especially at the dose of 250 and 500 mg/Kg. The phytochemical screening of S. henningsii revealed the presence of flavonoids, tannins and saponins which have been reported to increase the insulin secretion. The results obtained from this study demonstrated that the aqueous extract of S. henningsii possess antihyperglycemic and antilipidemic properties and thus could prevent various complications of diabetes. Generally, this study has validated the traditional use of this plant for the treatment of diabetes mellitus.
机译:在南部非洲的传统医学中,建议将Strychnos henningsii Gilg作为治疗糖尿病的其他方法之一。在链脲佐菌素-烟酰胺诱导的糖尿病大鼠中研究了口服125、250和500 mg / Kg体重的植物皮水提取物的抗糖尿病作用。在研究的三种剂量下,提取物降低了血糖水平,饲料和水的摄入量以及三酰甘油,而在250 mg / Kg的条件下获得了最佳结果。类似地,该提取物能够以500 mg / Kg显着降低胆固醇水平,而其余剂量与未治疗的糖尿病组相比没有任何明显的作用。另外,在所有剂量下,糖尿病治疗的大鼠的体重减轻均显着正常化。给予提取物90分钟后,糖尿病动物的葡萄糖耐量水平有效降低至接近正常水平,尤其是在250和500 mg / Kg的剂量下。亨氏链球菌的植物化学筛选显示存在类黄酮,单宁和皂苷,据报道它们可增加胰岛素的分泌。从该研究中获得的结果表明,亨氏链球菌的水提取物具有降血糖和抗血脂特性,因此可以预防糖尿病的各种并发症。通常,这项研究已经证实了这种植物在糖尿病治疗中的传统用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号